DE60236025D1 - Pharmazeutische zusammensetzung enthaltend l-arginin - Google Patents

Pharmazeutische zusammensetzung enthaltend l-arginin

Info

Publication number
DE60236025D1
DE60236025D1 DE60236025T DE60236025T DE60236025D1 DE 60236025 D1 DE60236025 D1 DE 60236025D1 DE 60236025 T DE60236025 T DE 60236025T DE 60236025 T DE60236025 T DE 60236025T DE 60236025 D1 DE60236025 D1 DE 60236025D1
Authority
DE
Germany
Prior art keywords
arginine
pharmaceutical composition
composition containing
pharmaceutically acceptable
solid form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236025T
Other languages
English (en)
Inventor
Harald Schmidt
Kirstin Wingler
Georg Komesker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PASCOE PHARM PRAEPARATE GmbH
Verinos Operations GmbH
Original Assignee
PASCOE PHARM PRAEPARATE GmbH
Vasopharm Biotech GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PASCOE PHARM PRAEPARATE GmbH, Vasopharm Biotech GmbH filed Critical PASCOE PHARM PRAEPARATE GmbH
Application granted granted Critical
Publication of DE60236025D1 publication Critical patent/DE60236025D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE60236025T 2002-08-22 2002-09-10 Pharmazeutische zusammensetzung enthaltend l-arginin Expired - Lifetime DE60236025D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0209395 2002-08-22
PCT/EP2002/010147 WO2004017955A1 (en) 2002-08-22 2002-09-10 L-arginine containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
DE60236025D1 true DE60236025D1 (de) 2010-05-27

Family

ID=31896810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236025T Expired - Lifetime DE60236025D1 (de) 2002-08-22 2002-09-10 Pharmazeutische zusammensetzung enthaltend l-arginin

Country Status (3)

Country Link
AT (1) ATE464043T1 (de)
DE (1) DE60236025D1 (de)
WO (1) WO2004017955A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018620A2 (en) * 2003-08-26 2005-03-03 Cell Center Cologne Gmbh Use of nitric oxide synthase (nos) cofactor for the treatment of sexual dysfunction
DK1708690T3 (en) 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
EP1964566A4 (de) * 2005-12-22 2009-01-07 Asubio Pharma Co Ltd Zubereitung mit verbesserter bioabsorption von sapropterin-hydrochlorid
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
BRPI0907646A2 (pt) * 2008-02-08 2015-07-21 Colgate Palmolive Co Composição sólida solúvel efervescente, e, método para limpar um disposotivo dental
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2011011092A1 (en) 2009-07-22 2011-01-27 University Of Massachusetts Methods and compositions to reduce oxidative stress
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
AU2013315750B9 (en) 2012-09-11 2018-11-15 Coherus Biosciences, Inc. Correctly folded etanercept in high purity and excellent yield
US20230228764A1 (en) * 2020-05-25 2023-07-20 Universiteit Maastricht Method for the diagnosis and treatment of essential primary hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008516A1 (fr) * 1996-08-30 1998-03-05 Suntory Limited Preparations servant a la prevention et au traitement de maladies provoquees par une hypofonction de l'oxyde nitrique synthase
US6063432A (en) * 1998-05-19 2000-05-16 Cooke Pharma Arginine or lysine containing fruit healthbar formulation
EP1163904B1 (de) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement

Also Published As

Publication number Publication date
ATE464043T1 (de) 2010-04-15
WO2004017955A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
MY147211A (en) Novel dihydropseudoerythromycin derivatives
NO20062644L (no) DPP-IV inhibitorer
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
BRPI0410219A (pt) composições farmacêuticas de vareniclina
HUP0201083A2 (hu) Új atorvastatinsók és az azokat tartalmazó gyógyszerkészítmények
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
DE60319707D1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
GB0212410D0 (en) Organic compounds
BRPI0407519A (pt) derivados de benzofurano
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
EA200701686A1 (ru) Свободное основание лерканидипина
RS51578B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
AU2003256108A1 (en) Organic acid salt of amlodipine
EP1325918A4 (de) Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
JP2004523567A5 (de)
BRPI0510704A (pt) tienopiridazinas como inibidores de ikk
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
MXPA04002640A (es) Esteres de analogos de 3-desoxi-vitamina d3.
ATE356118T1 (de) Moexipril-magnesium enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition